6505--Gallium Ga68 Doses Brand Name: NETSPOT

The Philadelphia VA Medical Center has a brand name only requirement for fifty-five (55) NETSPOT (Gallium Ga68) Doses, as-needed. NETSPOT is a radioactive tracer used in positron emission tomography (PET) scans for patients. The tracer is injected into the veins and can help providers determine where the tumors are and whether they've spread. This radiopharmaceutical will be used within an established Nuclear Medicine/PET imaging program requiring standardized preparation procedures, validated imaging protocols, established physician interpretation criteria, and compatibility with existing Gallium 69 radiolabeling workflows. • The total estimated value of this requirement is not explicitly stated, but it is mentioned that the requirement is for fifty-five (55) NETSPOT (Gallium Ga68) Doses, as-needed. • The product’s labeling, preparation methodology, imaging characteristics, and clinical use are already incorporated into the facility’s established Nuclear Medicine program. • The tracer is used to help providers look for certain types of hormone-releasing tumors, also known as neuroendocrine tumors (NET) in the body. • The tracer is injected into the veins and can help providers determine where the tumors are and whether they've spread.